Related Experiment Video
Updated: Jul 5, 2026
09:16
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
[Regenerative medicine for heart failure].
Noritoshi Nagaya1, Soichiro Kitamura
1Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 10, 2008
Summary
Mesenchymal stem cells (MSC) show promise for treating heart failure. These cells may regenerate heart tissue through differentiation and paracrine effects, leading to ongoing clinical trials for safety and efficacy.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart failure presents a significant global health challenge with high mortality rates.
- Current advanced treatments like mechanical circulatory support and cardiac transplantation have limitations.
- Mesenchymal stem cells (MSC) are a potential therapeutic option due to their regenerative capabilities.
Purpose of the Study:
- To explore the therapeutic potential of Mesenchymal stem cells (MSC) in addressing heart failure.
- To summarize the mechanisms by which MSC contribute to cardiac regeneration.
- To highlight the progression of MSC-based therapies from research to clinical trials.
Main Methods:
- Review of basic and translational research on Mesenchymal stem cells (MSC) in cardiac regeneration.
- Analysis of the differentiation potential of MSC into cardiomyocytes and vascular endothelial cells.
- Evaluation of the paracrine mechanisms, including secretion of angiogenic and antiapoptotic factors.
Main Results:
- Mesenchymal stem cells (MSC) possess multipotent differentiation capacity.
- MSC exert therapeutic effects through paracrine signaling, promoting angiogenesis and inhibiting apoptosis.
- Preclinical and translational research supports the investigation of MSC for heart failure.
Conclusions:
- Mesenchymal stem cells (MSC) offer a promising cell-based therapy for heart failure.
- The dual action of differentiation and paracrine effects underlies MSC's regenerative potential.
- Clinical trials are underway to assess the safety and efficacy of autologous MSC in heart failure patients.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.